Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model

Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model

Bone cancer pain control is difficult because it includes various characteristics of pain such as nociceptic and neuropathic pain. In this study, we investigated the effect of yokukansan (YKS), one of the traditional Japanese herbal medicines, on cancer pain in mouse bone metastasis model. Oral admi...

Full description

Bibliographic Details
Main Authors:	Kenta Nakao, Atsushi Fujiwara, Nobuyasu Komasawa, Denan Jin, Manabu Kitano, Sayuri Matsunami, Shinji Takai, Seiji Ito, Toshiaki Minami
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2019/2956920

Similar Items

Corrigendum to “Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model”
by: Kenta Nakao, et al.
Published: (2019-01-01)

Comparison of Pentax-AWS Airwayscope and Glidescope for Infant Tracheal Intubation by Anesthesiologists during Cardiopulmonary Arrest Simulation: A Randomized Crossover Trial
by: Shunsuke Fujiwara, et al.
Published: (2015-01-01)

Comparison of Direct and Indirect Laryngoscopes in Vomitus and Hematemesis Settings: A Randomized Simulation Trial
by: Ryosuke Mihara, et al.
Published: (2015-01-01)

Rapid-Sequence Intubation in the Left-Lateral Tilt Position in a Pregnant Woman with Premature Placental Abruption Utilizing a Videolaryngoscope
by: Kenta Nakao, et al.
Published: (2015-02-01)

Utility of a Gum-Elastic Bougie for Difficult Airway Management in Infants: A Simulation-Based Crossover Analysis
by: Nobuyasu Komasawa, et al.
Published: (2015-01-01)

Central venous access training simulator that enables dilator or catheter insertion
by: Nobuyasu Komasawa, et al.
Published: (2016-10-01)

Problem-based learning for anesthesia resident operating room crisis management training.
by: Nobuyasu Komasawa, et al.
Published: (2018-01-01)

Yokukansan enhances the proliferation of B65 neuroblastoma
by: Yoshihiko Nakatani, et al.
Published: (2017-01-01)

The Effect of the Kampo Medicine Yokukansan on Preoperative Anxiety and Sedation Levels
by: Young-Chang Arai, et al.
Published: (2014-01-01)

Comparison of Pressure Changes by Head and Neck Position between High-Volume Low-Pressure and Taper-Shaped Cuffs: A Randomized Controlled Trial
by: Nobuyasu Komasawa, et al.
Published: (2015-01-01)

Kampo Formulations, Chotosan, and Yokukansan, for Dementia Therapy: Existing Clinical and Preclinical Evidence
by: Kinzo Matsumoto, et al.
Published: (2013-01-01)

Yokukansan and its ingredients as possible treatment options for schizophrenia
by: Yu CH, et al.
Published: (2014-09-01)

Potential Application of Yokukansan as a Remedy for Parkinson’s Disease
by: Jung-Hee Jang, et al.
Published: (2018-01-01)

Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response.
by: Toru Hiratsuka, et al.
Published: (2010-10-01)

An educational program for decreasing catheter-related bloodstream infections in intensive care units: a pre- and post-intervention observational study
by: Yuichiro Shimoyama, et al.
Published: (2017-05-01)

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
by: Takeyoshi K, et al.
Published: (2016-03-01)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
by: Shinji Takai, et al.
Published: (2020-10-01)

Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
by: Shinji Takai, et al.
Published: (2018-02-01)

Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor–Knockout Mice
by: Shinji Takai, et al.
Published: (2013-01-01)

Yokukansan, a Traditional Japanese Medicine, Adjusts Glutamate Signaling in Cultured Keratinocytes
by: Maki Wakabayashi, et al.
Published: (2014-01-01)

Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells
by: Kazushige Mizoguchi, et al.
Published: (2017-09-01)

Yokukansan Enhances Pentobarbital-Induced Sleep in Socially Isolated Mice: Possible Involvement of GABAA – Benzodiazepine Receptor Complex
by: Nobuaki Egashira, et al.
Published: (2011-01-01)

Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
by: Tsuyoshi Miyaoka, et al.
Published: (2015-01-01)

Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion
by: Katahira H, et al.
Published: (2017-03-01)

Antiallodynic Effect of Herbal Medicine Yokukansan on Peripheral Neuropathy in Rats with Chronic Constriction Injury
by: Yasuyuki Suzuki, et al.
Published: (2012-01-01)

Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
by: Masahiro Tabuchi, et al.
Published: (2017-04-01)

Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
by: Kanada Y, et al.
Published: (2018-04-01)

The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells
by: Kazuki Terada, et al.
Published: (2018-08-01)

Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan
by: Takashi Matsumoto, et al.
Published: (2018-12-01)

Yokukansan (Kampo medicinal formula) prevents the development of morphine tolerance by inhibiting the secretion of orexin A
by: Ayami Katayama, et al.
Published: (2018-06-01)

Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice
by: Hironori Fujiwara, et al.
Published: (2017-04-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Chymase as an Important Target to Prevent Organ Damage
by: Shinji Takai, et al.
Published: (2010-01-01)

Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
by: Shinji Takai, et al.
Published: (2011-01-01)

Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats
by: Shinji Takai, et al.
Published: (2014-01-01)

Multiple Mechanisms for the Action of Chymase Inhibitors
by: Shinji Takai, et al.
Published: (2012-01-01)

Comparison of the relative importance of vascular and plasma drug concentrations to the hypotensive effect of telmisartan in rats
by: Shinji Takai, et al.
Published: (2016-02-01)

A postoperative left ventricular-right atrial shunt due to infectious endocarditis after aortic repair with aortic valve replacement detected by transesophageal echocardiography
by: Toshiyuki Sawai, et al.
Published: (2016-09-01)

Effect of Yokukansan on sleep disturbance and neuropathic pain in chronic constriction injury using a rat model
by: Deguchi, R., et al.
Published: (2021)

Matrix metalloproteinases in the process of invasion and metastasis of breast cancer
by: Konjević Gordana, et al.
Published: (2006-01-01)

Inhibitory effect of yokukansan on the decrease in the hippocampal excitatory amino acid transporter EAAT2 in stress-maladaptive mice
by: Hiroko Miyagishi, et al.
Published: (2017-10-01)